Close Menu

The Wall Street Journal reports on innovative approaches to getting people to enroll in clinical trials, including one that it describes as "a sort of medical matchmaker that is gaining wider usage: EmergingMed, a for-profit service that connects patients to cutting-edge clinical trials." Let's hope one of these programs works. While they may not realize it, consumers are an essential part of the biomedical enterprise and new treatments can't emerge without them.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

CBS This Morning highlights recent Medicare fraud involving offers of genetic testing.

Researchers find that many cancer drugs in development don't work quite how their developers thought they did, as Discover's D-brief blog reports.

Mariya Gabriel, a Bulgarian politician, is to be the next European Union research commissioner, according to Science.

In Science this week: a survey indicates that US adults are more likely to support the agricultural use of gene drives if they target non-native species and if they are limited, and more.